See, having not heard the audio, I haven't even understood these subgroup findings yet. I'm just going from the written paper announcement. The written announcement was bloody good yesterday, but if there are subgroups who only needed half as much OPT-302 to get a profound response...then this is even better than I first thought.
I wish I could offer antiVEGF-ABCD treatment to some of my patients right now.
This is a really exciting stock
explain the market cap, page-37
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
-0.010(1.09%) |
Mkt cap ! $1.114B | |||
| Open | High | Low | Value | Volume |
| 91.5¢ | 91.8¢ | 89.5¢ | $1.036M | 1.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31954 | 89.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 71302 | 3 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| OPT (ASX) Chart |